Format

Send to

Choose Destination
See comment in PubMed Commons below
Elife. 2015 Feb 3;4:e00662. doi: 10.7554/eLife.00662.

The evolution of drug resistance in clinical isolates of Candida albicans.

Author information

1
Department of Biology, Broad Institute of MIT and Harvard, Cambridge, United States.
2
Department of Genetics, Cell Biology and Development, University of Minnesota, Minneapolis, United States.
3
Department of Biology and Biotechnology, Worcester Polytechnic Institute, Worcester, United States.
4
Broad Institute of MIT and Harvard, Cambridge, United States.
5
School of Biological Sciences, University of Missouri at Kansas City, Kansas City, United States.

Abstract

Candida albicans is both a member of the healthy human microbiome and a major pathogen in immunocompromised individuals. Infections are typically treated with azole inhibitors of ergosterol biosynthesis often leading to drug resistance. Studies in clinical isolates have implicated multiple mechanisms in resistance, but have focused on large-scale aberrations or candidate genes, and do not comprehensively chart the genetic basis of adaptation. Here, we leveraged next-generation sequencing to analyze 43 isolates from 11 oral candidiasis patients. We detected newly selected mutations, including single-nucleotide polymorphisms (SNPs), copy-number variations and loss-of-heterozygosity (LOH) events. LOH events were commonly associated with acquired resistance, and SNPs in 240 genes may be related to host adaptation. Conversely, most aneuploidies were transient and did not correlate with drug resistance. Our analysis also shows that isolates also varied in adherence, filamentation, and virulence. Our work reveals new molecular mechanisms underlying the evolution of drug resistance and host adaptation.

KEYWORDS:

Candida albicans; drug resistance; evolution; evolutionary biology; genomics; infectious disease; microbiology; virulence

Comment in

PMID:
25646566
PMCID:
PMC4383195
DOI:
10.7554/eLife.00662
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for eLife Sciences Publications, Ltd Icon for PubMed Central
    Loading ...
    Support Center